The agreement comprises R&D, marketing and sales of imaging and therapy solutions in oncology and enables both companies to mutually leverage technologies and solutions. Proton therapy is considered to be one of the most advanced treatments for cancer.
In an interview to CNBC-TV18, Prathap C Reddy, executive chairman, Apollo Hospitals gave the details of the deal with IBA and why the company is keen on setting up better facilities in India. Reddy also mentions that the deal will not affect the business economic of Apollo Hospitals but rather add value.